231 related articles for article (PubMed ID: 12481883)
1. New vessel formation and aberrant VEGF/VEGFR signaling in acute leukemia: does it matter?
de Bont ES; Neefjes VM; Rosati S; Vellenga E; Kamps WA
Leuk Lymphoma; 2002 Oct; 43(10):1901-9. PubMed ID: 12481883
[TBL] [Abstract][Full Text] [Related]
2. The molecular perspective: VEGF and angiogenesis.
Goodsell DS
Stem Cells; 2003; 21(1):118-9. PubMed ID: 12529559
[No Abstract] [Full Text] [Related]
3. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
Zachary I
IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in acute and chronic leukemias.
Dickson DJ; Shami PJ
Leuk Lymphoma; 2001; 42(5):847-53. PubMed ID: 11697639
[TBL] [Abstract][Full Text] [Related]
5. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
6. VEGF and the quest for tumour angiogenesis factors.
Ferrara N
Nat Rev Cancer; 2002 Oct; 2(10):795-803. PubMed ID: 12360282
[TBL] [Abstract][Full Text] [Related]
7. Regulation of vascular permeability by vascular endothelial growth factors.
Bates DO; Harper SJ
Vascul Pharmacol; 2002 Nov; 39(4-5):225-37. PubMed ID: 12747962
[TBL] [Abstract][Full Text] [Related]
8. The biology of VEGF and its receptors.
Ferrara N; Gerber HP; LeCouter J
Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and its receptors in multiple myeloma.
Ria R; Roccaro AM; Merchionne F; Vacca A; Dammacco F; Ribatti D
Leukemia; 2003 Oct; 17(10):1961-6. PubMed ID: 14513045
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factors and angiogenesis in eye disease.
Witmer AN; Vrensen GF; Van Noorden CJ; Schlingemann RO
Prog Retin Eye Res; 2003 Jan; 22(1):1-29. PubMed ID: 12597922
[TBL] [Abstract][Full Text] [Related]
12. A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma.
Vacca A; Ria R; Ribatti D; Semeraro F; Djonov V; Di Raimondo F; Dammacco F
Haematologica; 2003 Feb; 88(2):176-85. PubMed ID: 12604407
[TBL] [Abstract][Full Text] [Related]
13. The role of vascular endothelial growth factor in angiogenesis.
Ferrara N; Gerber HP
Acta Haematol; 2001; 106(4):148-56. PubMed ID: 11815711
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic and lymphangiogenic molecules in hematological malignancies.
Orpana A; Salven P
Leuk Lymphoma; 2002 Feb; 43(2):219-24. PubMed ID: 11999550
[TBL] [Abstract][Full Text] [Related]
15. Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin.
Mackiewicz Z; Sukura A; Povilenaité D; Ceponis A; Virtanen I; Hukkanen M; Konttinen YT
Clin Exp Rheumatol; 2002; 20(5):641-6. PubMed ID: 12412194
[TBL] [Abstract][Full Text] [Related]
16. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
Ferrara N
Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
[TBL] [Abstract][Full Text] [Related]
17. The molecular perspective: VEGF and angiogenesis.
Goodsell DS
Oncologist; 2002; 7(6):569-70. PubMed ID: 12490744
[No Abstract] [Full Text] [Related]
18. [Expression of vascular endothelial growth factor and its receptors in endometrial carcinoma].
Wang H; Chen G; Zhang B
Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):391-5. PubMed ID: 12485477
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.
Padró T; Bieker R; Ruiz S; Steins M; Retzlaff S; Bürger H; Büchner T; Kessler T; Herrera F; Kienast J; Müller-Tidow C; Serve H; Berdel WE; Mesters RM
Leukemia; 2002 Jul; 16(7):1302-10. PubMed ID: 12094254
[TBL] [Abstract][Full Text] [Related]
20. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
